 |
|
Colchicine as First-Choice Therapy for Recurrent Pericarditis
Results of the CORE (COlchicine for REcurrent pericarditis) Trial
Massimo Imazio, MD;
Marco Bobbio, MD;
Enrico Cecchi, MD;
Daniela Demarie, MD;
Franco Pomari, MD;
Mauro Moratti, MD;
Aldo Ghisio, MD;
Riccardo Belli, MD;
Rita Trinchero, MD
Arch Intern Med. 2005;165:1987-1991.
Background Colchicine seems to be a good drug for treating recurrences of pericarditis after conventional treatment failure, but no clinical trial has tested the effects of colchicine as first-line drug for the treatment of the first recurrence of pericarditis.
Methods A prospective, randomized, open-label design was used to investigate the safety and efficacy of colchicine therapy as adjunct to conventional therapy for the first episode of recurrent pericarditis. Eighty-four consecutive patients with a first episode of recurrent pericarditis were randomly assigned to receive conventional treatment with aspirin alone or conventional treatment plus colchicine (1.0-2.0 mg the first day and then 0.5-1.0 mg/d for 6 months). When aspirin was contraindicated, prednisone (1.0-1.5 mg/kg daily) was given for 1 month and then was gradually tapered. The primary end point was the recurrence rate. Intention-to-treat analyses were performed by treatment group.
Results During 1682 patient-months (mean follow-up, 20 months), treatment with colchicine significantly decreased the recurrence rate (actuarial rates at 18 months were 24.0% vs 50.6%; P = .02; number needed to treat = 4.0; 95% confidence interval 2.5-7.1) and symptom persistence at 72 hours (10% vs 31%; P = .03). In multivariate analysis, previous corticosteroid use was an independent risk factor for further recurrences (odds ratio, 2.89; 95% confidence interval, 1.10-8.26; P = .04). No serious adverse effects were observed.
Conclusion Colchicine therapy led to a clinically important and statistically significant benefit over conventional treatment, decreasing the recurrence rate in patients with a first episode of recurrent pericarditis.
Author Affiliations: Cardiology Department, Maria Vittoria Hospital (Drs Imazio, Cecchi, Demarie, Pomari, Moratti, Ghisio, Belli, and Trinchero), and Cardiology Medical School, University of Torino (Dr Bobbio), Torino, Italy.
RELATED LETTER
Colchicine for Recurrent Acute Pericarditis
Antonio Brucato, Giovanni Brambilla, Yehuda Adler, and David H. Spodick
Arch Intern Med. 2006;166(6):696.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation
Imazio et al.
Circulation 2008;118:667-671.
ABSTRACT
| FULL TEXT
First line treatment with colchicine reduced recurrent pericarditis
Flather and Collinson
Evid. Based Med. 2006;11:44-44.
FULL TEXT
Colchicine for recurrent acute pericarditis.
Brucato et al.
Arch Intern Med 2006;166:696-696.
FULL TEXT
Colchicine for Recurrent Pericarditis
JWatch General 2005;2005:4-4.
FULL TEXT
|
